Who backs Soufflé Therapeutics?
13 investors| Investor | Type |
|---|---|
| Bessemer Venture Partners | Growth equity |
| Temasek Holdings | Other |
| Breyer Capital | Venture capital |
| ARCH Venture Partners | Venture capital |
| Safar Partners | Venture capital |
| Polaris Partners | Venture capital |
| The Invus Group | PE / buyout |
| AbbVie Ventures | — |
| Amgen | — |
| Janus Henderson Investors | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Soufflé Therapeutics investors
13 investors are on record for Soufflé Therapeutics, including Bessemer Venture Partners, Temasek Holdings, Breyer Capital and ARCH Venture Partners. By type, the record holds 4 venture capital firms, 1 private equity firm and 1 growth equity firm. The Series A in Oct 2025 drew 9 investors.
Free account
More of Soufflé Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Soufflé Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Soufflé Therapeutics in therapeutic devices. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View